Safety of antithyroid drugs in pregnancy: update and therapy implications

References

• Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018 May;14(5):301–316.
   PubMed Web of Science ®Google Scholar
• Garmendia Madariaga A, Santos Palacios S, Guillen-Grima F, et al. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014 Mar;99(3):923–931.
   PubMed Web of Science ®Google Scholar
• Smith TJ, Hegedus L, Longo DL. Graves’ disease. N Engl J Med. 2016 Oct 20;375(16):1552–1565.
   PubMed Web of Science ®Google Scholar
• Carlé A, Pedersen IB, Knudsen N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol. 2011 May;164(5):801–809.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Carle A, et al. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab. 2015 Mar;100(3):1164–1171.
   PubMed Web of Science ®Google Scholar
• Dong AC, Stagnaro-Green A. Differences in diagnostic criteria mask the true prevalence of thyroid disease in pregnancy: a systematic review and meta-analysis. Thyroid. 2019 Feb;29(2):278–289.
   PubMed Web of Science ®Google Scholar
• Brandt F, Green A, Hegedüs L, et al. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol. 2011 Oct;165(4):491–497.
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Taylor PN, Evans C, et al. Primary therapy of Graves’ disease and cardiovascular morbidity and mortality: a linked-record cohort study. Lancet Diabetes Endocrinol. 2019 Apr;7(4):278–287.
   PubMed Web of Science ®Google Scholar
• Bartalena L, Tanda ML. Clinical practice. Graves’ ophthalmopathy. N Engl J Med. 2009 Mar;360(10):994–1001.
   PubMed Web of Science ®Google Scholar
• Wiersinga WM. Quality of life in Graves’ ophthalmopathy. Best Pract Res Clin Endocrinol Metab. 2012 June;26(3):359–370.
   PubMed Web of Science ®Google Scholar
• Burch HB, Wartofsky L. Life-threatening thyrotoxicosis Thyroid storm. Endocrinol Metab Clin North Am. 1993 June;22(2):263–277.
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Lazarus JH. Important considerations in the management of Graves’ disease in pregnant women. Expert Rev Clin Immunol. 2015;11(8):947–957.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Spontaneous abortion, stillbirth and hyperthyroidism: a danish population-based study. Eur Thyroid J. 2014 Sept;3(3):164–172.
   PubMedGoogle Scholar
• Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol. 1994 Dec;84(6):946–949.
   PubMed Web of Science ®Google Scholar
• Davis LE, Lucas MJ, Hankins GD, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol. 1989 Jan;160(1):63–70.
   PubMed Web of Science ®Google Scholar
• Medici M, Korevaar TI, Schalekamp-Timmermans S, et al. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab. 2014 Dec;99(12):E2591–8.
   PubMed Web of Science ®Google Scholar
• McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992 Summer;2(2):155–159.
   PubMed Web of Science ®Google Scholar
• Evans C, Gregory JW, Barton J, et al. Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case series. Ann Clin Biochem. 2011;48(4):386–390.
   PubMed Web of Science ®Google Scholar
• Bucci I, Giuliani C, Napolitano G. Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne). 2017;8:137.
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol. 2006 Feb;107(2 Pt 1):337–341.
   PubMed Web of Science ®Google Scholar
• Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid. 1998 Sept;8(9):859–864.
   PubMed Web of Science ®Google Scholar
• Burch HB, Cooper DS. ANNIVERSARY REVIEW: antithyroid drug therapy: 70 years later. Eur J Endocrinol. 2018Oct12;179(5):R261–r274.
   PubMed Web of Science ®Google Scholar
• Cooper DS. Antithyroid drugs. N Engl J Med. 2005 Mar;352(9):905–917.
   PubMed Web of Science ®Google Scholar
• Marchant B, Brownlie BE, Hart DM, et al. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab. 1977 Dec;45(6):1187–1193.
   PubMed Web of Science ®Google Scholar
• Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab. 1997 Sept;82(9):3099–3102.
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab. 1997 Nov;82(11):3633–3636.
   PubMed Web of Science ®Google Scholar
• Gardner DF, Cruikshank DP, Hays PM, et al. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab. 1986 Jan;62(1):217–220.
   PubMed Web of Science ®Google Scholar
• Nakamura H, Miyauchi A, Miyawaki N, et al. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab. 2013 Dec;98(12):4776–4783.
   PubMed Web of Science ®Google Scholar
• Tajiri J, Noguchi S, Murakami T, et al. Antithyroid drug-induced agranulocytosis The usefulness of routine white blood cell count monitoring. Arch Intern Med. 1990 Mar;150(3):621–624.
   PubMedGoogle Scholar
• Andersen SL, Olsen J, Laurberg P. Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab. 2016 Apr;101(4):1606–1614.
   PubMed Web of Science ®Google Scholar
• Wang MT, Lee WJ, Huang TY, et al. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study. Br J Clin Pharmacol. 2014 Sept;78(3):619–629.
   PubMed Web of Science ®Google Scholar
• Suzuki N, Noh JY, Hiruma M, et al. Analysis of antithyroid drug-induced severe liver injury in 18,558 newly diagnosed patients with Graves’ disease in Japan. Thyroid. 2019 Oct;29(10):1390–1398.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Knosgaard L, Olsen J, et al. Maternal thyroid function, use of antithyroid drugs in early pregnancy, and birth defects. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6040–6048.
   PubMed Web of Science ®Google Scholar
• Seo GH, Kim TH, Chung JH. Antithyroid drugs and congenital malformations: a nationwide Korean cohort study. Ann Intern Med. 2018Jan; 23:405–413.
   Web of Science ®Google Scholar
• Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of Graves‘ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab. 2012;97 United States.(7):2396–2403.
   PubMed Web of Science ®Google Scholar
• Khanolkar MP, Owen PJD, Lazarus JH. Propylthiouracil induced ANCA positive vasculitis: a case report [Case Report]. Int J Endocrinol Metab. 2004;2(1):47–50.
   Google Scholar
• Ben Hamou A, Banu I, Dupuy O. An underestimate iatrogenic effect of antithyroid drugs: acute pancreatitis. Presse Med. 2019 Nov;48(11 Pt 1):1334–1336.
   PubMed Web of Science ®Google Scholar
• Tonacchera M, Chiovato L, Bartalena L, et al. Treatment of Graves’ hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy. J Endocrinol Invest. 2020 Feb;43(2):257–265.
   PubMed Web of Science ®Google Scholar
• Medicines and Healthcare Products Regulatory Agency. Carbimazole: risk of acute pancreatitis; 2019 [cited 2019 Dec 16]. Available from: https://www.gov.uk/drug-safety-update/carbimazole-risk-of-acute-pancreatitis
   Google Scholar
• Yang M, Qu H, Deng HC. Acute pancreatitis induced by methimazole in a patient with Graves’ disease. Thyroid. 2012 Jan;22(1):94–96.
   PubMed Web of Science ®Google Scholar
• Chng CL, Kek PC, Khoo DHC. Carbimazole-induced acute pancreatitis and cholestatic hepatitis.. Endocr Pract. 2011 Nov–Dec;17(6):960–961.
   PubMed Web of Science ®Google Scholar
• Taguchi M, Yokota M, Koyano H, et al. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves’ disease. Clin Endocrinol (Oxf). 1999 Nov;51(5):667–670.
   PubMed Web of Science ®Google Scholar
• Kikuchi I, Miyata N, Yoshimura Y, et al. Methimazole-induced acute pancreatitis: a case report. Clin J Gastroenterol. 2019 June;12(3):239–242.
   PubMed Web of Science ®Google Scholar
• Jung JH, Hahm JR, Jung J, et al. Acute pancreatitis induced by methimazole treatment in a 51-year-old korean man: a case report. J Korean Med Sci. 2014 Aug;29(8):1170–1173.
   PubMed Web of Science ®Google Scholar
• Abraham A, Raghavan P, Patel R, et al. Acute pancreatitis induced by methimazole therapy. Case Rep Gastroenterol. 2012 May;6(2):223–231.
   PubMedGoogle Scholar
• Agito K, Manni A. Acute pancreatitis induced by methimazole in a patient with subclinical hyperthyroidism. J Investig Med High Impact Case Rep. 2015; Apr–June;3(2):2324709615592229.
   Web of Science ®Google Scholar
• Marazuela M, de Paco Sanchez G, Jimenez I, et al. Acute pancreatitis, hepatic cholestasis, and erythema nodosum induced by carbimazole treatment for Graves’ disease. Endocr J. 2002 June;49(3):315–318.
   PubMed Web of Science ®Google Scholar
• Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. J Clin Gastroenterol. 2005 Sept;39(8):709–716.
   PubMed Web of Science ®Google Scholar
• Lai SW, Lin CL, Liao KF. Use of methimazole and risk of acute pancreatitis: a case-control study in Taiwan. Indian J Pharmacol. 2016 Mar–Apr;48(2):192–195.
   PubMed Web of Science ®Google Scholar
• Brix TH, Lund LC, Henriksen DP, et al. Acute pancreatitis is significantly increased among methimazole, but not propylthiouracil users. Evidence from a nationwide, case-crossover, and case-control study. Short Call Abstract. 42nd Annual Meeting of the European Thyroid Association. Budapest; 2019.
   Google Scholar
• Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Metab Toxicol. 2015 Feb;11(2):243–257.
   PubMed Web of Science ®Google Scholar
• Hallberg P, Eriksson N, Ibanez L, et al. Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol. 2016 June;4(6):507–516.
   PubMed Web of Science ®Google Scholar
• Takata K, Kubota S, Fukata S, et al. Methimazole-induced agranulocytosis in patients with Graves’ disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid. 2009 June;19(6):559–563.
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Rosa C, Christensen RD. Transplacental passage of recombinant human granulocyte colony-stimulating factor in women with an imminent preterm delivery. Am J Obstet Gynecol. 1996 Apr;174(4):1306–1311.
   PubMed Web of Science ®Google Scholar
• Davison S, Lennard TW, Davison J, et al. Management of a pregnant patient with Graves’ disease complicated by thionamide-induced neutropenia in the first trimester. Clin Endocrinol (Oxf). 2001 Apr;54(4):559–561.
   PubMed Web of Science ®Google Scholar
• Cho YY, Shon HS, Yoon HD. Management of a pregnant patient with Graves’ disease complicated by propylthiouracil induced agranulocytosis. Korean J Intern Med. 2005 Dec;20(4):335–338.
   PubMedGoogle Scholar
• Finucane FM, O’Connell J, Kinsley BT. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves’ thyrotoxicosis in pregnancy. Ir J Med Sci. 2008 Mar;177(1):69–71.
   PubMed Web of Science ®Google Scholar
• Murji A, Sobel ML, Feig DS, et al. Propylthiouracil-induced agranulocytosis in the third trimester of pregnancy. Obstet Gynecol. 2010 Aug;116(Suppl 2):485–487.
   PubMed Web of Science ®Google Scholar
• Thomas SK, Sheffield JS, Roberts SW. Thionamide-induced neutropenia and ecthyma in a pregnant patient with hyperthyroidism. Obstet Gynecol. 2013 Aug;122(2 Pt 2):490–492.
   PubMed Web of Science ®Google Scholar
• Lim S, Shireene V, Vijay A, et al. Carbimazole-related agranulocytosis in pregnancy - a case report. J Health Trans Med. 2007 June;25(1):33–38.
   Google Scholar
• Akmal A, Kung J. Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity. Expert Opin Drug Saf. 2014 Oct;13(10):1397–1406.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab. 2009;94(6):1881–1882.
   PubMed Web of Science ®Google Scholar
• Taylor PN, Vaidya B. Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J. 2012;1(3):176–185.
   PubMedGoogle Scholar
• Bahn RS, Burch HS, Cooper DS, et al. The role of propylthiouracil in the management of Graves’ disease in adults: report of a meeting jointly sponsored by the American thyroid association and the food and drug administration. Thyroid. 2009 July;19(7):673–674.
   PubMedGoogle Scholar
• Rivkees SA. 63 years and 715 days to the “boxed warning”: unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol. 2010;2010:658267.
   PubMedGoogle Scholar
• Zou H, Jin L, Wang LR, et al. Methimazole-induced cholestatic hepatitis: two cases report and literature review. Oncotarget. 2015 Oct 19;7:5088.
   Google Scholar
• Yang J, Li LF, Xu Q, et al. Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China. Thyroid. 2015 Mar;25(3):278–283.
   PubMed Web of Science ®Google Scholar
• Kontoleon P, Ilias I, Koutras DA, et al. Successful treatment with carbimazole of a hyperthyroid pregnancy with hepatic impairment after propylthiouracil administration: a case report. Clin Exp Obstet Gynecol. 2002;29(4):304–305.
   PubMedGoogle Scholar
• Ruiz JK, Rossi GV, Vallejos HA, et al. Fulminant hepatic failure associated with propylthiouracil. Ann Pharmacother. 2003 Feb;37(2):224–228.
   PubMed Web of Science ®Google Scholar
• Sequeira E, Wanyonyi S, Dodia R. Severe propylthiouracil-induced hepatotoxicity in pregnancy managed successfully by liver transplantation: a case report. J Med Case Rep. 2011 Sept;19(5):461.
   Google Scholar
• Taylor P, Bhatt S, Gouni R, et al. A case of propylthiouracil-induced hepatitis during pregnancy. Eur Thyroid J. 2012 Apr;1(1):41–44.
   PubMedGoogle Scholar
• Miyamura T, Kanda T, Minemura S, et al. Acute liver failure associated with propylthiouracil in a pregnant 26-year-old woman. Case Rep Gastroenterol. 2013 May;7(2):240–244.
   PubMedGoogle Scholar
• Fung SC, Wyssusek KH. Hyperthyroidism and propylthiouracil-induced liver failure in pregnancy. Anaesth Intensive Care. 2015 Nov;43(6):793–794.
   PubMed Web of Science ®Google Scholar
• Bartnik CM, Maheshwari RN, Subramanian RM. Beating the odds: a full-term delivery after liver transplantation of a pregnant hyperthyroid patient at 19 weeks’ gestation for propylthiouracil-induced acute liver failure. Transplant Proc. 2018 Dec;50(10):3995–3999.
   PubMed Web of Science ®Google Scholar
• Hayashida CY, Duarte AJ, Sato AE, et al. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest. 1990 Dec;13(11):937–941.
   PubMed Web of Science ®Google Scholar
• Milham S Jr., Elledge W. Maternal methimazole and congenital defects in children. Teratology. 1972;5(1):125.
   Google Scholar
• Milham S Jr. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy. Teratology. 1985 Oct;32(2):321.
   PubMedGoogle Scholar
• Mujtaba Q, Burrow GN. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol. 1975 Sept;46(3):282–286.
   PubMed Web of Science ®Google Scholar
• Bachrach LK, Burrow GN. Aplasia cutis congenita and methimazole. Can Med Assoc J. 1984 May 15;130(10):1264.
   PubMed Web of Science ®Google Scholar
• Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet. 1999;83(1):43–46.
   PubMed Web of Science ®Google Scholar
• Karlsson FA, Axelsson O, Melhus H. Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab. 2002 Feb;87(2):947–949.
   PubMed Web of Science ®Google Scholar
• Bowman P, Vaidya B. Suspected spontaneous reports of birth defects in the UK associated with the use of carbimazole and propylthiouracil in pregnancy. J Thyroid Res. 2011;2011:235130.
   PubMedGoogle Scholar
• Bowman P, Osborne NJ, Sturley R, et al. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy. QJM. 2012;105(2):189–193.
   PubMed Web of Science ®Google Scholar
• Alexander EK, Pearce EN, Brent GA, et al. 2017 guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid. 2017 Mar;27(3):315–389.
   PubMed Web of Science ®Google Scholar
• Khan I, Okosieme O, Lazarus J. Antithyroid drug therapy in pregnancy: a review of guideline recommendations. Expert Rev Endocrinol Metab. 2017 July;12(4):269–278.
   PubMed Web of Science ®Google Scholar
• Wing DA, Millar LK, Koonings PP, et al. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol. 1994 Jan;170(1 Pt 1):90–95.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab. 2013 Nov;98(11):4373–4381.
   PubMed Web of Science ®Google Scholar
• Korelitz JJ, McNally DL, Masters MN, et al. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid. 2013 June;23(6):758–765.
   PubMed Web of Science ®Google Scholar
• Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. Adverse effects of prenatal methimazole exposure. Teratology. 2001;64(5):262–266.
   PubMedGoogle Scholar
• Lian XL, Bai Y, Xu YH, et al. [Effects of maternal hyperthyroidism and antithyroid drug therapy on congenital malformation of newborn infants]. Zhonghua Fu Chan Ke Za Zhi. 2005 Aug;40(8):511–515.
   PubMedGoogle Scholar
• Rosenfeld H, Ornoy AF, Shechtman S, et al. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol. 2009;68(4):609–617.
   PubMed Web of Science ®Google Scholar
• Clementi M, Di Gianantonio E, Cassina M, et al. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab. 2010;95(11):E337–E341.
   PubMed Web of Science ®Google Scholar
• Chen CH, Xirasagar S, Lin CC, et al. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG. 2011 Oct;118(11):1365–1373.
   PubMed Web of Science ®Google Scholar
• Andersen SL, Lonn S, Vestergaard P, et al. Birth defects after use of antithyroid drugs in early pregnancy: a Swedish nationwide study. Eur J Endocrinol. 2017 Oct;177(4):369–378.
   PubMed Web of Science ®Google Scholar
• Gianetti E, Russo L, Orlandi F, et al. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy. J Endocrinol Invest. 2015 Sept;38(9):977–985.
   PubMed Web of Science ®Google Scholar
• Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf). 1984 June;20(6):695–700.
   PubMed Web of Science ®Google Scholar
• Lo JC, Rivkees S, Chandra M, et al. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid. 2015 Mar;25(6):698–705.
   PubMed Web of Science ®Google Scholar
• SL A, Olsen J Fau WCS, Wu Cs Fau -Laurberg P, et al. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid. 2014;24(10):1533–1540.
   PubMed Web of Science ®Google Scholar
• Pedersen RN, Calzolari E, Husby S, et al. Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions. Arch Dis Child. 2012 Mar;97(3):227–232.
   PubMed Web of Science ®Google Scholar
• Case AP, Mitchell LE. Prevalence and patterns of choanal atresia and choanal stenosis among pregnancies in Texas, 1999–2004. Am J Med Genet A. 2011 Apr;155(a4):786–791.
   Web of Science ®Google Scholar
• Laurberg P, Andersen SL. Antithyroid drug use in pregnancy and birth defects: why some studies find clear associations, and some studies report none. Thyroid. 2015 Nov;25(11):1185–1190.
   PubMed Web of Science ®Google Scholar
• Li H, Zheng J, Luo J, et al., Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies. PloS One. 2015;10(5):e0126610.
   PubMed Web of Science ®Google Scholar
• Li X, Liu GY, Ma JL, et al. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis. Clinics (Sao Paulo). 2015 June;70(6):453–459.
   PubMed Web of Science ®Google Scholar
• Song R, Lin H, Chen Y, et al., Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: a meta-analysis. PloS One. 2017;12(7):e0180108.
   PubMed Web of Science ®Google Scholar
• Yu W, Wu N, Li L, et al. Side effects of Ptu and Mmi in the treatment of hyperthyroidism: a systematic review and meta-analysis. Endocr Pract. 2020 Feb;26(2):207–217.
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Khan I, Taylor PN. Preconception management of thyroid dysfunction. Clin Endocrinol (Oxf). 2018 Sept;89(3):269–279.
   PubMed Web of Science ®Google Scholar
• Medicines and Healthcare Products Regulatory Agency. Carbimazole: increased risk of congenital malformations; strengthened advice on contraception; 2019 [cited 2019 Dec 16]. Available from: https://www.gov.uk/drug-safety-update/carbimazole-increased-risk-of-congenital-malformations-strengthened-advice-on-contraception
   Google Scholar
• Kahaly GJ, Bartalena L, Hegedüs L, et al. 2018 European thyroid association guideline for the management of Graves’ hyperthyroidism. Eur Thyroid J. 2018;7(4):167–186.
   PubMed Web of Science ®Google Scholar
• Ross DS, Burch HB, Cooper DS, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016 Oct;26(10):1343–1421.
   PubMed Web of Science ®Google Scholar
• Burch HB, Burman KD, Cooper DS. A 2011 survey of clinical practice patterns in the management of Graves’ disease. J Clin Endocrinol Metab. 2012 Dec;97(12):4549–4558.
   PubMed Web of Science ®Google Scholar
• NICE. Thyroid disease guidelines: national institute of health and care excellence; 2019 [cited 2019 Nov 16]. Available from: https://www.nice.org.uk/guidance/indevelopment/gid-ng10074/documents
   Google Scholar
• Astwood EB. Landmark article May 8, 1943: treatment of hyperthyroidism with thiourea and thiouracil By E.B. Astwood. JAMA. 1984 Apr 6;251(13):1743–1746.
   PubMed Web of Science ®Google Scholar
• Yoshihara A, Noh JY, Watanabe N, et al. Substituting potassium iodide for methimazole as the treatment for Graves’ disease during the first trimester may reduce the incidence of congenital anomalies: a retrospective study at a single medical institution in Japan. Thyroid. 2015 Oct;25(10):1155–1161.
   PubMed Web of Science ®Google Scholar
• Yoshihara A, Noh JY, Watanabe N, et al. Characteristics of patients with Graves’ disease whose thyroid hormone levels increase after substituting potassium iodide for methimazole in the first trimester of pregnancy. Thyroid. 2020 Feb 10;30(3):451–456.
   Web of Science ®Google Scholar
• Vita R, Lapa D, Vita G, et al. A patient with stress-related onset and exacerbations of Graves disease. Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):55–61.
   PubMedGoogle Scholar
• Benvenga S, Lapa D, Cannavo S, et al. Successive thyroid storms treated with L-carnitine and low doses of methimazole. Am J Med. 2003 Oct 1;115(5):417–418.
   PubMed Web of Science ®Google Scholar